Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Nursing Interventions for Pain and Sleep Management in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Scoping Review

AI Summary
  • Direct evidence for nurse led pain and sleep interventions during immune checkpoint inhibitor treatment is scarce; most evidence derives from broader oncology populations.
  • Electronic patient reported outcome monitoring showed promise in one immune checkpoint inhibitor trial for symptom management.
  • Sleep assessment lacked validated sleep specific instruments and no ICI specific nursing intervention primarily targeted insomnia; future research should address this.
Summarise with AI (MRCPsych/FRANZCP)

Nurs Open. 2026 Nov;13(11):e71022. doi: 10.1002/nop2.71022.

ABSTRACT

AIM: To map nursing interventions for pain and sleep disturbance among adults receiving immune checkpoint inhibitors and identify assessment and research gaps.

DESIGN: A scoping review.

REVIEW METHODS: Eligible sources were charted using a standardized form and descriptively synthesized by intervention type, outcome, study design and evidence stream.

DATA SOURCES: PubMed, Scopus, ScienceDirect and the Cumulative Index to Nursing and Allied Health Literature were searched on 30 November 2025 for English-language sources published from 1 January 2019 to 30 November 2025.

RESULTS: We included 10 sources: one randomized clinical trial, four systematic reviews, three of which included meta-analysis, three observational studies, one mixed-methods study and one structured clinical perspective/review. Four sources provided direct evidence from populations receiving immune checkpoint inhibitors, whereas six provided potentially transferable evidence from broader oncology populations. Electronic patient-reported outcome monitoring produced promising findings in one immune checkpoint inhibitor trial. Broader oncology evidence identified potentially transferable pain-management approaches. Two primary studies explicitly reported sleep-related findings, but neither reported using a dedicated, validated sleep-specific instrument. Sleep-related content within broader symptom or quality-of-life assessments was distinguished from dedicated sleep assessment. No included ICI-specific nursing intervention primarily targeted insomnia.

CONCLUSION: Direct evidence for nurse-led pain and sleep interventions during immune checkpoint inhibitor treatment remains limited. Findings from broader oncology populations should not be interpreted as evidence of effectiveness in this population.

IMPLICATIONS FOR THE PROFESSION AND/OR PATIENT CARE: Oncology nurses may consider assessing pain and sleep separately. Future research should incorporate validated sleep measures and explore interventions tailored to patients receiving immune checkpoint inhibitors.

IMPACT: The study addressed the limited nursing evidence for managing pain and sleep disturbance during immune checkpoint inhibitor treatment. The main findings were the scarcity of direct intervention evidence and the absence of validated sleep-specific assessment. The findings will inform oncology nurses, researchers and services caring for adults receiving immune checkpoint inhibitors.

REPORTING METHOD: The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews.

PATIENT OR PUBLIC CONTRIBUTION: No patients or members of the public were involved in this review, which was based on published evidence.

PMID:43008261 | DOI:10.1002/nop2.71022

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD